Comparative Study of Significance of Serum Cystatin-C, Serum Creatinine and Microalbuminuria Estimation in Patients of Early Diabetic Nephropathy

Abstract

Background: Diabetes has become the most common single cause of End Stage Renal Disease (ESRD) in most countries. About 20-30% of patients with type 1 or type 2 Diabetes develop evidence of nephropathy. Recent studies have now demonstrated that the onset and course of DN can be ameliorated to a significant degree by several interventions but these interventions have their greatest impact if instituted at a point very early in the course of the development of this complication.